A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy
Clinical trial NCT00074854 · COMPLETED
Trial details
- NCT number
- NCT00074854
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.